Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$792K Buy
600
+93
+18% +$127K 0.04% 151
2025
Q4
$542K Sell
507
-13
-3% -$13.6K 0.03% 184
2025
Q3
$503K Buy
520
+105
+25% +$82.5K 0.03% 188
2025
Q2
$333K Buy
+415
New +$298K 0.02% 230

Other funds holding ASML

Klingman & Associates's ASML Position: Q1 2026 in Review

Klingman & Associates increased its ASML (ASML) stake by 18% in Q1 2026, buying an estimated $127K and bringing the position to 600 shares worth $792K. The position accounts for 0.04% of the portfolio, ranked #151.

Klingman & Associates first reported a position in ASML in Q2 2025 and has held it in 4 quarters since. 2,188 funds tracked by Wall St. Rank hold ASML as of Q1 2026.

  • Klingman & Associates held 600 shares of ASML worth $792K as of Q1 2026.
  • Klingman & Associates bought 93 ASML shares in Q1 2026, an estimated $127K.
  • ASML made up 0.04% of Klingman & Associates's portfolio in Q1 2026, its #151 holding.
  • Klingman & Associates first reported a position in ASML in Q2 2025 and has held it in 4 quarters since.
  • 2,188 funds tracked by Wall St. Rank held ASML as of Q1 2026.

Based on Klingman & Associates's 13F filing for Q1 2026, filed 14 May 2026.